HRT Financial’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-239,907
| Closed | -$3.69M | – | 4001 |
|
|
2025
Q4 | $3.69M | Sell |
239,907
-68,237
| -22% | -$752K | 0.01% | 936 |
|
|
2025
Q3 | $3.06M | Buy |
308,144
+144,532
| +88% | +$1.5M | 0.01% | 920 |
|
|
2025
Q2 | $1.62M | Sell |
163,612
-34,679
| -17% | -$365K | 0.01% | 1020 |
|
|
2025
Q1 | $2.57M | Buy |
+198,291
| New | +$2.62M | 0.02% | 705 |
|
|
2024
Q4 | – | Sell |
-121,740
| Closed | -$1.36M | – | 2590 |
|
|
2024
Q3 | $1.36M | Buy |
+121,740
| New | +$1.34M | 0.01% | 1069 |
|
|
2024
Q1 | – | Sell |
-18,993
| Closed | -$265K | – | 2489 |
|
|
2023
Q4 | $265K | Buy |
+18,993
| New | +$264K | ﹤0.01% | 1668 |
|
|
2023
Q2 | – | Sell |
-205,344
| Closed | -$2.01M | – | 2642 |
|
|
2023
Q1 | $2.01M | Buy |
+205,344
| New | +$2.19M | 0.02% | 593 |
|
|
2022
Q4 | – | Sell |
-31,749
| Closed | -$331K | – | 2608 |
|
|
2022
Q3 | $331K | Buy |
+31,749
| New | +$414K | ﹤0.01% | 1932 |
|
|
2022
Q2 | – | Sell |
-25,372
| Closed | -$275K | – | 3093 |
|
|
2022
Q1 | $275K | Sell |
25,372
-36,978
| -59% | -$449K | ﹤0.01% | 2290 |
|
|
2021
Q4 | $877K | Buy |
62,350
+38,515
| +162% | +$634K | 0.01% | 1242 |
|
|
2021
Q3 | $457K | Buy |
23,835
+11,554
| +94% | +$153K | ﹤0.01% | 2076 |
|
|
2021
Q2 | $120K | Sell |
12,281
-154,488
| -93% | -$1.4M | ﹤0.01% | 2549 |
|
|
2021
Q1 | $1.64M | Buy |
+166,769
| New | +$1.37M | 0.02% | 721 |
|
Other funds holding DVAX
HRT Financial's DVAX Position: Q1 2026 in Review
HRT Financial sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 239,907 shares — an estimated $3.69M sold.
HRT Financial first reported a position in DVAX in Q1 2021 and held it in 13 quarters. The position peaked at $3.69M in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.
- HRT Financial reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
- HRT Financial sold 239,907 Dynavax Technologies shares in Q1 2026, an estimated $3.69M.
- HRT Financial first reported a position in Dynavax Technologies in Q1 2021 and held it in 13 quarters.
- HRT Financial's Dynavax Technologies position peaked at $3.69M in Q4 2025.
- 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.
Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.